A stromal gene signature associated with inflammatory breast cancer
暂无分享,去创建一个
John N Weinstein | Ming Yi | Mark Reimers | Brian T Luke | J. Weinstein | R. Stephens | M. Yi | S. Ambs | B. Luke | J. Ludwig | H. Yfantis | Dong H. Lee | M. Reimers | B. Boersma | Stefan Ambs | Joseph A Ludwig | Brenda J Boersma | Robert M Stephens | Harry G Yfantis | Dong H Lee | D. Lee
[1] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[2] K. Gish,et al. Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers , 2004, Oncogene.
[3] R. Salunga,et al. Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] Howard Y. Chang,et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] Peter Horak,et al. Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinoma , 2005, Cancer.
[6] J. Chirgwin,et al. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[8] M. Morrow,et al. Surgical aspects of inflammatory breast cancer. , 2005, Breast disease.
[9] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[10] Identifying pre-post chemotherapy differences in gene expression in breast tumours: a statistical method appropriate for this aim , 2002, British Journal of Cancer.
[11] S. Steinberg,et al. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] Julie E Goodman,et al. Association of breast cancer outcome with status of p53 and MDM2 SNP309. , 2006, Journal of the National Cancer Institute.
[13] Jing Li,et al. Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues. , 2005, Gastroenterology.
[14] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[15] M. Reth,et al. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion , 2003, Nature Immunology.
[16] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[18] K. Tryggvason,et al. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. , 1995, Cancer research.
[19] Luc Y Dirix,et al. Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression Quantification , 2004, Clinical Cancer Research.
[20] Rosette Lidereau,et al. Molecular Profiling of Inflammatory Breast Cancer , 2004, Clinical Cancer Research.
[21] S. Merajver,et al. Persistent E-Cadherin Expression in Inflammatory Breast Cancer , 2001, Modern Pathology.
[22] S. Gruber,et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway , 2006, Nature Cell Biology.
[23] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] Tilman Brummer,et al. Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1 , 2006, Nature Immunology.
[25] S. Ambs,et al. Inflammation and IGF‐I activate the Akt pathway in breast cancer , 2007, International journal of cancer.
[26] Hiroyuki Yamamoto,et al. Expression of the g 2 Chain of Laminin-5 at the Invasive Front Is Associated with Recurrence and Poor Prognosis in Human Esophageal Squamous Cell Carcinoma 1 , 2001 .
[27] A. Buzdar,et al. Inflammatory breast carcinoma incidence and survival , 1998, Cancer.
[28] H. Kleinman,et al. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. , 2005, Cancer research.
[29] L. Kiesel,et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] P. Dam,et al. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling , 2006, Breast Cancer Research and Treatment.
[31] E. van Marck,et al. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] N. Crawford,et al. Germ line polymorphism in metastatic progression. , 2006, Cancer research.
[33] S. Hilsenbeck,et al. Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype , 2006, Clinical Cancer Research.
[34] B. A. Ballif,et al. Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] F. Antonicelli,et al. The small leucine-rich proteoglycan lumican inhibits melanoma progression. , 2004, Experimental cell research.
[36] Peter H Watson,et al. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] S. Ménard,et al. SEL1L a multifaceted protein playing a role in tumor progression , 2006, Journal of cellular physiology.
[38] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[39] P. Levine,et al. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. , 1985, Journal of the National Cancer Institute.
[40] Hiroyuki Yamamoto,et al. Expression of the γ2 Chain of Laminin-5 at the Invasive Front Is Associated with Recurrence and Poor Prognosis in Human Esophageal Squamous Cell Carcinoma , 2001 .
[41] Ming Yi,et al. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data , 2006, BMC Bioinformatics.
[42] Daniel Birnbaum,et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. , 2005, Cancer research.
[43] S. Devesa,et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. , 2005, Journal of the National Cancer Institute.
[44] K. Sekiguchi,et al. Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. , 2003, Cancer research.
[45] S. Nasim,et al. Evaluation of a linear amplification method for small samples used on high-density oligonucleotide microarray analysis. , 2004, Analytical biochemistry.
[46] A. Howell,et al. Occurrence of a fetal fibroblast phenotype in familial breast cancer , 1986, International journal of cancer.
[47] Andrea Bild,et al. Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy , 2006, Clinical Cancer Research.
[48] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[49] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[51] S. Merajver,et al. Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants , 2000, Breast Cancer Research.
[52] S. Swain,et al. Clinical aspects of inflammatory breast cancer. , 2005, Breast disease.
[53] S. Merajver,et al. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[54] I. Kurochkin,et al. ALEX1, a novel human armadillo repeat protein that is expressed differentially in normal tissues and carcinomas. , 2001, Biochemical and biophysical research communications.
[55] F. Bertucci,et al. Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy , 2004, Cancer Research.
[56] Wei Wang,et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. , 2004, Cancer cell.
[57] T. Brabletz,et al. Expression of the Invasion Factor Laminin γ2 in Colorectal Carcinomas Is Regulated by β-Catenin , 2001 .
[58] Luc Y. Dirix,et al. Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis , 2005, Breast Cancer Research and Treatment.
[59] K J Millen,et al. The ZIC gene family in development and disease , 2005, Clinical genetics.